245 related articles for article (PubMed ID: 37808345)
21. miR-122 promotes hepatic lipogenesis via inhibiting the LKB1/AMPK pathway by targeting Sirt1 in non-alcoholic fatty liver disease.
Long JK; Dai W; Zheng YW; Zhao SP
Mol Med; 2019 Jun; 25(1):26. PubMed ID: 31195981
[TBL] [Abstract][Full Text] [Related]
22. Methyl ferulic acid attenuates ethanol-induced hepatic steatosis by regulating AMPK and FoxO1 Pathways in Rats and L-02 cells.
Cheng Q; Li YW; Yang CF; Zhong YJ; He H; Zhu FC; Li L
Chem Biol Interact; 2018 Aug; 291():180-189. PubMed ID: 29940154
[TBL] [Abstract][Full Text] [Related]
23. 3-Caffeoyl, 4-dihydrocaffeoylquinic acid from Salicornia herbacea attenuates high glucose-induced hepatic lipogenesis in human HepG2 cells through activation of the liver kinase B1 and silent information regulator T1/AMPK-dependent pathway.
Pil Hwang Y; Gyun Kim H; Choi JH; Truong Do M; Tran TP; Chun HK; Chung YC; Jeong TC; Jeong HG
Mol Nutr Food Res; 2013 Mar; 57(3):471-82. PubMed ID: 23349077
[TBL] [Abstract][Full Text] [Related]
24. Linalool attenuates lipid accumulation and oxidative stress in metabolic dysfunction-associated steatotic liver disease via Sirt1/Akt/PPRA-α/AMPK and Nrf-2/HO-1 signaling pathways.
Tamilmani P; Sathibabu Uddandrao VV; Chandrasekaran P; Saravanan G; Brahma Naidu P; Sengottuvelu S; Vadivukkarasi S
Clin Res Hepatol Gastroenterol; 2023 Dec; 47(10):102231. PubMed ID: 37865226
[TBL] [Abstract][Full Text] [Related]
25. Effects of the new thiazolidine derivative LPSF/GQ-02 on hepatic lipid metabolism pathways in non-alcoholic fatty liver disease (NAFLD).
Araújo S; Soares E Silva A; Gomes F; Ribeiro E; Oliveira W; Oliveira A; Lima I; Lima MDC; Pitta I; Peixoto C
Eur J Pharmacol; 2016 Oct; 788():306-314. PubMed ID: 27349145
[TBL] [Abstract][Full Text] [Related]
26. Alisol A 24-Acetate Prevents Hepatic Steatosis and Metabolic Disorders in HepG2 Cells.
Zeng L; Tang W; Yin J; Feng L; Li Y; Yao X; Zhou B
Cell Physiol Biochem; 2016; 40(3-4):453-464. PubMed ID: 27889747
[TBL] [Abstract][Full Text] [Related]
27. Kaempferol attenuates nonalcoholic fatty liver disease in type 2 diabetic mice via the Sirt1/AMPK signaling pathway.
Li N; Yin L; Shang J; Liang M; Liu Z; Yang H; Qiang G; Du G; Yang X
Biomed Pharmacother; 2023 Sep; 165():115113. PubMed ID: 37418974
[TBL] [Abstract][Full Text] [Related]
28. Berbamine induced AMPK activation regulates mTOR/SREBP-1c axis and Nrf2/ARE pathway to allay lipid accumulation and oxidative stress in steatotic HepG2 cells.
Sharma A; Anand SK; Singh N; Dwivedi UN; Kakkar P
Eur J Pharmacol; 2020 Sep; 882():173244. PubMed ID: 32526241
[TBL] [Abstract][Full Text] [Related]
29. Patchouli alcohol ameliorates skeletal muscle insulin resistance and NAFLD via AMPK/SIRT1-mediated suppression of inflammation.
Pyun DH; Kim TJ; Park SY; Lee HJ; Abd El-Aty AM; Jeong JH; Jung TW
Mol Cell Endocrinol; 2021 Dec; 538():111464. PubMed ID: 34601002
[TBL] [Abstract][Full Text] [Related]
30. Effects of dibutyl phthalate on lipid metabolism in liver and hepatocytes based on PPARα/SREBP-1c/FAS/GPAT/AMPK signal pathway.
Zhang W; Li JY; Wei XC; Wang Q; Yang JY; Hou H; Du ZW; Wu XA
Food Chem Toxicol; 2021 Mar; 149():112029. PubMed ID: 33508418
[TBL] [Abstract][Full Text] [Related]
31. Hovenia Dulcis Extract Reduces Lipid Accumulation in Oleic Acid-Induced Steatosis of Hep G2 Cells via Activation of AMPK and PPARα/CPT-1 Pathway and in Acute Hyperlipidemia Mouse Model.
Kim B; Woo MJ; Park CS; Lee SH; Kim JS; Kim B; An S; Kim SH
Phytother Res; 2017 Jan; 31(1):132-139. PubMed ID: 27762456
[TBL] [Abstract][Full Text] [Related]
32. Hugan Qingzhi medication ameliorates hepatic steatosis by activating AMPK and PPARα pathways in L02 cells and HepG2 cells.
Yin J; Luo Y; Deng H; Qin S; Tang W; Zeng L; Zhou B
J Ethnopharmacol; 2014 May; 154(1):229-39. PubMed ID: 24735863
[TBL] [Abstract][Full Text] [Related]
33. 6-Gingerol regulates triglyceride and cholesterol biosynthesis to improve hepatic steatosis in MAFLD by activating the AMPK-SREBPs signaling pathway.
Xia Q; Lu F; Chen Y; Li J; Huang Z; Fang K; Hu M; Guo Y; Dong H; Xu L; Gong J
Biomed Pharmacother; 2024 Jan; 170():116060. PubMed ID: 38147735
[TBL] [Abstract][Full Text] [Related]
34. Protopanaxadiol ameliorates NAFLD by regulating hepatocyte lipid metabolism through AMPK/SIRT1 signaling pathway.
Li Y; Liu Y; Chen Z; Tang K; Yang L; Jiang Y; Wang J; Huang P; Wang J; Zheng P; Song H
Biomed Pharmacother; 2023 Apr; 160():114319. PubMed ID: 36724639
[TBL] [Abstract][Full Text] [Related]
35. Effects of
Mun J; Park J; Yoon HG; You Y; Choi KC; Lee YH; Kim K; Lee J; Kim OK; Jun W
J Med Food; 2019 Dec; 22(12):1262-1270. PubMed ID: 31834842
[TBL] [Abstract][Full Text] [Related]
36. Puerarin ameliorates hepatic steatosis by activating the PPARα and AMPK signaling pathways in hepatocytes.
Kang OH; Kim SB; Mun SH; Seo YS; Hwang HC; Lee YM; Lee HS; Kang DG; Kwon DY
Int J Mol Med; 2015 Mar; 35(3):803-9. PubMed ID: 25605057
[TBL] [Abstract][Full Text] [Related]
37. Oxyresveratrol ameliorates nonalcoholic fatty liver disease by regulating hepatic lipogenesis and fatty acid oxidation through liver kinase B1 and AMP-activated protein kinase.
Lee JH; Baek SY; Jang EJ; Ku SK; Kim KM; Ki SH; Kim CE; Park KI; Kim SC; Kim YW
Chem Biol Interact; 2018 Jun; 289():68-74. PubMed ID: 29702089
[TBL] [Abstract][Full Text] [Related]
38. Heat-Killed
Lee JH; Woo KJ; Hong J; Han KI; Kim HS; Kim TJ
Int J Mol Sci; 2023 Feb; 24(5):. PubMed ID: 36901915
[TBL] [Abstract][Full Text] [Related]
39. Selenium and vitamin B
Zhang Q; Zhou X; Zhang J; Li Q; Qian Z
Nutr Res; 2022 Oct; 106():101-118. PubMed ID: 36183668
[TBL] [Abstract][Full Text] [Related]
40. Sulforaphane Attenuates Nonalcoholic Fatty Liver Disease by Inhibiting Hepatic Steatosis and Apoptosis.
Li J; Xie S; Teng W
Nutrients; 2021 Dec; 14(1):. PubMed ID: 35010950
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
